← Back to the page you were readingYou opened this term from another page.
IP · ProsecutionTask: Draft and prosecute

Request for continued examination (RCE)

Also called RCE, continued examination, 37 CFR 1.114 request

Published by Patsnap Team Updated 6 sources
DefinitionRCE

Request for continued examination (RCE) is a US procedure under which an applicant may obtain continued examination of an application in which prosecution is closed, by filing a submission and the fee set forth in 37 CFR 1.17(e)2. It rests on 35 U.S.C. 132(b) and does not require the applicant to file a continuing application1,3.

If an applicant timely files the submission and fee, the Office withdraws the finality of any Office action and the submission is entered and considered (37 CFR 1.114(d))2. An RCE is not the filing of a new application3. This page covers US law. See Patent prosecution, Continuation application and Patent term adjustment.

Used byUS applicants whose application is under a final action, a notice of allowance or appeal2
Comes upAfter a final rejection or allowance, when the applicant wants to amend, argue, add evidence or file an IDS2
Governed by35 U.S.C. 132(b), 37 CFR 1.114 and MPEP 706.07(h)1,2,3
Not to confuse withA continuation application: an RCE is not the filing of a new application, and the Office will not convert one into the other3
01

When an RCE can be filed

An RCE is available only when prosecution is closed. Under 37 CFR 1.114(b), that means the application is under appeal, or the last Office action is a final action (37 CFR 1.113), a notice of allowance (37 CFR 1.311), or an action that otherwise closes prosecution2. The MPEP says an applicant cannot request continued examination until prosecution is closed3.

The request must be filed before the earliest of: payment of the issue fee, unless a petition under 37 CFR 1.313 is granted; abandonment of the application; or the filing of a notice of appeal to the Federal Circuit under 35 U.S.C. 141, or the commencement of a civil action under 35 U.S.C. 145 or 146, unless the appeal or civil action is terminated (37 CFR 1.114(a))2.

What it must include. A submission and the fee set forth in 37 CFR 1.17(e). A submission includes, but is not limited to, an information disclosure statement, an amendment to the written description, claims or drawings, new arguments, or new evidence in support of patentability. If a reply to an Office action under 35 U.S.C. 132 is outstanding, the submission must meet the reply requirements of 37 CFR 1.111 (37 CFR 1.114(c))2. So after a final rejection, a submission consisting only of an information disclosure statement is not enough3. An appeal brief or reply brief, or related papers, is not a submission, but the MPEP says a submission may consist of the arguments in a previously filed appeal brief or reply brief, or of a statement incorporating them by reference2,3. An RCE filed after appeal but before a decision on the appeal is treated as a request to withdraw the appeal and reopen prosecution before the examiner (37 CFR 1.114(d))2.

02

What an RCE cannot do

  • Applications outside the rule. The RCE provisions do not apply to a provisional application, a design patent application, an international design application, a patent under reexamination, certain applications filed before June 8, 1995, or an international application that does not comply with 35 U.S.C. 371 (37 CFR 1.114(e))2.
  • Design applications. The MPEP says RCE practice does not apply to design applications. Effective July 14, 2003, a continued prosecution application (CPA) under 37 CFR 1.53(d) may only be filed if the prior nonprovisional application is a design application3.
  • Switching inventions. An applicant cannot file an RCE to obtain continued examination on the basis of claims independent and distinct from the claims previously claimed and examined as a matter of right. Newly submitted claims to such an invention are withdrawn from consideration and not entered3.
  • Becoming a new application. An RCE is not the filing of a new application, so the Office will not convert an RCE to a new application such as one filed under 37 CFR 1.53(b), or to a CPA3.
  • National stage applications. For an effective RCE in a 35 U.S.C. 371 national stage application, all required inventor's oaths or declarations, or substitute statements, must be submitted before or with the RCE3.
03

Effect on patent term adjustment

Under 35 U.S.C. 154(b)(1)(B), if issue of an original patent is delayed because the USPTO fails to issue it within 3 years after the actual filing date (or, for an international application, the commencement of the national stage), the term is extended 1 day for each day after the end of that 3-year period until the patent issues. The statute excludes from that calculation any time consumed by continued examination of the application requested by the applicant under 35 U.S.C. 132(b)4.

So time spent in continued examination after an RCE does not count toward that 3-year guarantee4. Other rules also limit adjustment: where periods of delay overlap, the adjustment cannot exceed the actual number of days issuance was delayed (35 U.S.C. 154(b)(2)(A)), and the adjustment is reduced by any period in which the applicant failed to engage in reasonable efforts to conclude prosecution (35 U.S.C. 154(b)(2)(C)(i))4. Filing an RCE after a notice of allowance has been mailed also reduces any adjustment, by the days from the day after the date of mailing of the notice of allowance to the date the request was filed (37 CFR 1.704(c)(12))6. This page does not cover the other grounds for adjustment. See Patent term adjustment.

04

RCE vs continuing application

RouteWhat it is
Request for continued examinationContinued examination of the same application after prosecution is closed, on a submission and the 37 CFR 1.17(e) fee. It does not require a continuing application under 37 CFR 1.53(b)2,3.
Continuing application under 37 CFR 1.53(b)A new application with its own filing date, which can claim the benefit of the earlier application if it names a common inventor and is filed while the earlier application is pending (35 U.S.C. 120)5. The Office will not convert an RCE into one3.
Continued prosecution application (CPA) under 37 CFR 1.53(d)Available only where the prior nonprovisional application is a design application3.
05

Questions people ask

Patsnap EurekaEureka IP

Draft and prosecute

Patent Drafting AI Agent

An AI agent that drafts claims and a full specification from a disclosure, with a compliance review before you finish.

Start drafting
When can I file an RCE?

Only after prosecution is closed, meaning the application is under appeal or the last Office action is a final action, a notice of allowance or an action that otherwise closes prosecution, and before payment of the issue fee (unless a petition under 37 CFR 1.313 is granted), abandonment, or the filing of an appeal to the Federal Circuit or a civil action2.

Can I file an RCE in a design application?

No. The RCE provisions do not apply to a design patent application (37 CFR 1.114(e)(4))2. The MPEP says a continued prosecution application under 37 CFR 1.53(d) is available where the prior nonprovisional application is a design application3.

Does an RCE affect patent term adjustment?

It can. The 3-year guarantee in 35 U.S.C. 154(b)(1)(B) does not count any time consumed by continued examination requested by the applicant under 35 U.S.C. 132(b)4. An RCE filed after a notice of allowance has been mailed also reduces any adjustment (37 CFR 1.704(c)(12))6. Other grounds and limits on adjustment are outside this page4.

Can I add claims to a different invention in an RCE?

No. An applicant cannot use an RCE to obtain continued examination on claims independent and distinct from those previously claimed and examined as a matter of right. Such newly submitted claims are withdrawn from consideration and not entered3.

06

How it connects

Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toPatentability search: a practical guideCheck whether an invention is new before you spend on a filing.GuideRead
  • 02 / AI agentNovelty Search AI AgentAn AI agent that searches prior art for your invention and compares each reference with it feature by feature.Patsnap EurekaRun it
  • 03 / Free toolPatent draft style studioRewrite a technical description in claim language.AI resultTry tool
PublishedPatsnap Team
Updated 27 October 2026
Sources
  1. 35 U.S. Code § 132: Notice of rejection; reexamination. Legal Information Institute, Cornell Law School. Accessed 22 October 2026.
  2. 37 CFR 1.114: Request for continued examination. Legal Information Institute, Cornell Law School. Accessed 22 October 2026.
  3. MPEP 706.07(h): Request for Continued Examination (RCE) Practice [R-01.2024]. United States Patent and Trademark Office (USPTO). Accessed 22 October 2026.
  4. 35 U.S. Code § 154: Contents and term of patent; provisional rights. Legal Information Institute, Cornell Law School. Accessed 22 October 2026.
  5. 35 U.S. Code § 120: Benefit of earlier filing date in the United States. Legal Information Institute, Cornell Law School. Accessed 27 October 2026.
  6. 37 CFR § 1.704: Reduction of period of adjustment of patent term. Legal Information Institute, Cornell Law School (Code of Federal Regulations). Accessed 27 October 2026.
Disclaimer

General information only. This page explains a term for general information and reference only. It is not legal, accounting, tax or other professional advice and must not be relied upon as such. It does not create an attorney-client or other professional relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text. To the extent permitted by law, this page is provided as is, without any warranty that it is complete, accurate or current, and Patsnap accepts no liability for loss arising from reliance on it. See also Patsnap’s website Disclaimer.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 27 October 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Third-party names, marks and links. Names of courts, government bodies, parties, people, companies, standards and products appear for identification only. Some of these names are trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap. Links to third-party sources are provided for reference, and Patsnap is not responsible for their content or availability.

Patsnap Eureka. Patsnap publishes this glossary and also offers Patsnap Eureka, a commercial product mentioned on this page. Those mentions describe what its tools are designed to do, not what they will find in a particular case. Their outputs are research aids and should be reviewed by a qualified professional before being relied on.

Corrections and requests. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why. If you are named on this page, or your concern is about legal rights or personal information, email legal@patsnap.com. We review reports and may correct or update the page.

Patent Drafting AI AgentStart drafting in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.